Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stock Now Rated “Moderate Buy” by Wall Street Brokerages
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy […]
3 Oct 08:44 · The Markets Daily